Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Cash Flows from Operating Activities:
Net income	$ 15,101	$ 10,376
Operating distributions received from unconsolidated joint ventures	0	209
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	30,768	31,782
Amortization of debt issuance costs	409	425
Other amortization	20,129	17,685
Stock compensation expense	2,897	2,469
Equity in income of unconsolidated joint ventures	(11)	(115)
Loss on sale of real estate assets, net	53	20
Changes in assets and liabilities:
Increase in tenant and straight-line rent receivables, net	(6,043)	(5,131)
(Increase)/decrease in restricted cash and escrows	(216)	4,409
Decrease/(increase) in prepaid expenses and other assets	1,921	(18)
Increase in accounts payable and accrued expenses	(17,008)	(13,225)
Increase in deferred income	2,253	822
Net cash provided by operating activities	50,253	49,708
Cash Flows from Investing Activities:
Capitalized expenditures, net of accruals	(28,203)	(26,537)
Net sales proceeds from wholly-owned properties	(64)	45,400
Investments in unconsolidated joint ventures	(284)	0
Deferred lease costs paid	(4,270)	(2,860)
Net cash (used in)/provided by investing activities	(32,821)	16,003
Cash Flows from Financing Activities:
Debt issuance costs paid	(63)	(99)
Proceeds from debt	100,000	178,000
Repayments of debt	(55,345)	(205,262)
Costs of issuance of common stock	0	(42)
Shares withheld to pay tax obligations related to employee stock compensation	(1,128)	(541)
Repurchases of common stock as part of announced plan	0	(7,943)
Dividends paid and discount on dividend reinvestments	(61,080)	(30,533)
Net cash used in financing activities	(17,616)	(66,420)
Net decrease in cash and cash equivalents	(184)	(709)
Cash and cash equivalents, beginning of period	6,992	5,441
Cash and cash equivalents, end of period	6,808	4,732
Supplemental Disclosures of Significant Noncash Investing and Financing Activities:
Accrued dividends and discount on dividend reinvestments	(30,532)	0
Accrued capital expenditures and deferred lease costs	$ 12,478	$ 11,876